Abstract
The nose is a filter for air particles and infectious agents. The local immune system is well developed in the nose and the paranasal sinuses and is of major importance in controlling incoming infections. In the first part, we will describe this innate and adaptive immunity with its cells and mediators. However, under certain circumstances, the local inflammation persists and can result in diseases such as allergic and nonallergic rhinitis and chronic rhinosinusitis with and without nasal polyposis. These pathologies and their characterizing inflammation are described in the second part. Recent insights have emphasized the importance of this local nasal inflammation. The understanding of inflammatory cells, mediators, and pathways in different populations is essential to have a clear insight into the pathogenesis. Finally, we focus on local inflammation as a target for therapy. Phenotyping and endotyping based on local inflammation are important in tailoring the right treatment for the right patient. In nasal polyposis, we find a local IgE-mediated inflammation, independent of the presence of allergy, which can be treated successfully by anti-IgE treatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AID:
-
Activation-induced cytidine deaminase
- BCGF:
-
B-cell growth factor
- Bcl6:
-
B-cell CLL lymphoma-6
- BCR:
-
B-cell receptor
- Blimp1:
-
B-lymphocyte-induced maturation protein 1
- BSF-1:
-
B-cell stimulatory factor-1 = IL-4
- c-Maf:
-
Musculoaponeurotic fibrosarcoma oncogene homolog
- C-region:
-
Constant carboxy-terminal region
- CCR-7:
-
C-C chemokine receptor type 7
- CD:
-
Cluster of differentiation
- CDR:
-
Complementary-determining region
- CSF:
-
Colony-stimulating factors
- CSIF:
-
Cytokine synthesis inhibitory factor
- CXCL-13:
-
C-X-C chemokine ligand
- CXCR-5:
-
C-X-C chemokine receptor type 5
- DC:
-
Dendritic cells
- Fab:
-
The antigen-binding site
- FOXP3:
-
Forkhead box protein P3
- GATA-3:
-
GATA-binding protein 3
- GM-CSF:
-
Granulocyte-macrophage colony-stimulating factor
- HMW-BCGF:
-
High molecular weight B-cell growth factor
- ICOS:
-
Inducible co-stimulator
- IFN:
-
Interferons
- IFNγ:
-
Interferon-γ
- Ig:
-
Immunoglobulins
- Ih2:
-
Innate helper type 2 cells
- IL:
-
Interleukin
- IRF-4:
-
Interferon regulatory factor 4
- iTreg cells:
-
The inducible Treg cells
- LPS:
-
Lipopolysaccharide
- M1:
-
Classically activated macrophages
- MAF:
-
Macrophage-activating factor
- MHC:
-
Major histocompatibility complex molecule
- MPP type 2:
-
Multipotent progenitor cells
- NAP:
-
Neutrophil-activating protein
- NARES:
-
Nonallergic rhinitis with eosinophilia syndrome
- NHC:
-
Natural helper cells
- NK:
-
Natural killer cells
- NLR:
-
NOD-like receptors
- nTreg cells:
-
The naturally occurring Treg cells
- PAMP:
-
Pathogen-associated molecular patterns
- PpL:
-
Protein L of streptococcus magnus
- RAG proteins:
-
Recombination-activating gene proteins
- RORγt:
-
RAR-related orphan receptor gamma
- SA:
-
Staphylococcus aureus
- SAE:
-
Staphylococcus aureus enterotoxins
- SCF:
-
Stem Cell Factor
- SED:
-
Staphylococcal enterotoxin D
- SHM:
-
Somatic hypermutation
- SpA:
-
Protein A of Staphylococcus aureus
- TBX 21:
-
T-box protein 21
- TCR:
-
T-cell receptor
- Tfh cells:
-
T follicular helper cells
- TGFβ:
-
Tissue growth factor β
- Th:
-
T helper cells
- TLR:
-
Toll-like receptors
- TNF:
-
Tumor necrosis factors
- TNFβ:
-
Tumor necrosis factor-β
- Treg:
-
T regulatory cells
- TSLP:
-
Thymic stromal lymphopoietin
- V-region:
-
Variable amino-terminal region
- VDJ gene segment:
-
Variable diversity, or joining gene segment
- Vβ:
-
Variable β-chain
References
Adamovic S, Amundsen SS, et al. Association study of IL2/IL21 and FcgRIIa: significant association with the IL2/IL21 region in Scandinavian coeliac disease families. Genes Immun. 2008;9(4):364–7.
Alam R, Forsythe P, et al. Transforming growth factor beta abrogates the effects of hematopoietins on eosinophils and induces their apoptosis. J Exp Med. 1994;179(3):1041–5.
Bachert C, Patou J, et al. The role of sinus disease in asthma. Curr Opin Allergy Clin Immunol. 2006;6(1):29–36.
Bachert C, Gevaert P, et al. Role of staphylococcal superantigens in airway disease. Chem Immunol Allergy. 2007;93:214–36.
Bachert C, Zhang N, et al. Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma. J Allergy Clin Immunol. 2010;126(5):962–8. 968 e961–966.
Barlow JL, McKenzie AN. Nuocytes: expanding the innate cell repertoire in type-2 immunity. J Leukoc Biol. 2011;90(5):867–74.
Barlow JL, Bellosi A, et al. Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity. J Allergy Clin Immunol. 2012;129(1):191–8. e191–194.
Bennett CL, Christie J, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet. 2001;27(1):20–1.
Ediger D, Sin BA, et al. Airway inflammation in nasal polyposis: immunopathological aspects of relation to asthma. Clin Exp Allergy. 2005;35(3):319–26.
Fairweather D, Cihakova D. Alternatively activated macrophages in infection and autoimmunity. J Autoimmun. 2009;33(3–4):222–30.
Fazilleau N, Mark L, et al. Follicular helper T cells: lineage and location. Immunity. 2009;30(3):324–35.
Fort MM, Cheung J, et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity. 2001;15(6):985–95.
Gevaert P, Holtappels G, et al. Organization of secondary lymphoid tissue and local IgE formation to Staphylococcus aureus enterotoxins in nasal polyp tissue. Allergy. 2005;60(1):71–9.
Gevaert P, Van Bruaene N, et al. Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis. J Allergy Clin Immunol. 2011;128(5):989–95. e1-8.
Gevaert P, Calus L, et al. Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma. J Allergy Clin Immunol. 2012;pii:S0091-6749(12)01294-8.
Gould HJ, Sutton BJ. IgE in allergy and asthma today. Nat Rev Immunol. 2008;8(3):205–17.
Groot Kormelink T, Calus L, et al. Local free light chain expression is increased in chronic rhinosinusitis with nasal polyps. Allergy. 2012;67(9):1165–72.
Hammad H, Lambrecht BN. Dendritic cells and epithelial cells: linking innate and adaptive immunity in asthma. Nat Rev Immunol. 2008;8(3):193–204.
Hammad H, Plantinga M, et al. Inflammatory dendritic cells–not basophils–are necessary and sufficient for induction of Th2 immunity to inhaled house dust mite allergen. J Exp Med. 2010;207(10):2097–111.
Headley MB, Zhou B, et al. TSLP conditions the lung immune environment for the generation of pathogenic innate and antigen-specific adaptive immune responses. J Immunol. 2009;182(3):1641–7.
Jankowski R. Eosinophils in the pathophysiology of nasal polyposis. Acta Otolaryngol. 1996;116(2):160–3.
Kang K, Reilly SM, et al. Adipocyte-derived Th2 cytokines and myeloid PPARdelta regulate macrophage polarization and insulin sensitivity. Cell Metab. 2008;7(6):485–95.
Kaplan AP. Allergy. 2nd ed. New York: Saunders; 1997.
King C, Tangye SG, et al. T follicular helper (TFH) cells in normal and dysregulated immune responses. Annu Rev Immunol. 2008;26:741–66.
KleinJan A, Vinke JG, et al. Local production and detection of (specific) IgE in nasal B-cells and plasma cells of allergic rhinitis patients. Eur Respir J. 2000;15(3):491–7.
Kotzin BL, Leung DY, et al. Superantigens and their potential role in human disease. Adv Immunol. 1993;54:99–166.
Koyasu S, Moro K. Innate Th2-type immune responses and the natural helper cell, a newly identified lymphocyte population. Curr Opin Allergy Clin Immunol. 2011;11(2):109–14.
Krysko O, Holtappels G, et al. Alternatively activated macrophages and impaired phagocytosis of S. Aureus in chronic rhinosinusitis. Allergy. 2011;66(3):396–403.
Maurer D, Stingl G. Immunoglobulin E-binding structures on antigen-presenting cells present in skin and blood. J Invest Dermatol. 1995;104(5):707–10.
Maurer D, Fiebiger S, et al. Peripheral blood dendritic cells express Fc epsilon RI as a complex composed of Fc epsilon RI alpha- and Fc epsilon RI gamma-chains and can use this receptor for IgE-mediated allergen presentation. J Immunol. 1996;157(2):607–16.
Mills KH, McGuirk P. Antigen-specific regulatory T cells–their induction and role in infection. Semin Immunol. 2004;16(2):107–17.
Neill DR, McKenzie AN. Nuocytes and beyond: new insights into helminth expulsion. Trends Parasitol. 2011;27(5):214–21.
Neill DR, Wong SH, et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature. 2010;464(7293):1367–70.
Novak N, Allam JP, et al. Characterization of FcepsilonRI-bearing CD123 blood dendritic cell antigen-2 plasmacytoid dendritic cells in atopic dermatitis. J Allergy Clin Immunol. 2004;114(2):364–70.
Oliphant CJ, Barlow JL, et al. Insights into the initiation of type 2 immune responses. Immunology. 2011;134(4):378–85.
Patou J, Gevaert P, et al. Staphylococcus aureus enterotoxin B, protein A, and lipoteichoic acid stimulations in nasal polyps. J Allergy Clin Immunol. 2008;121(1):110–5.
Pawankar R, Okuda M, et al. Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the Fc epsilonRI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells. J Clin Invest. 1997;99(7):1492–9.
Pawankar R, Mori M, et al. Overview on the pathomechanisms of allergic rhinitis. Asia Pac Allergy. 2011;1(3):157–67.
Plager DA, Kahl JC, et al. Gene transcription changes in asthmatic chronic rhinosinusitis with nasal polyps and comparison to those in atopic dermatitis. PLoS One. 2010;5(7):e11450.
Powe DG, Bonnin AJ, et al. ‘Entopy’: local allergy paradigm. Clin Exp Allergy. 2010;40(7):987–97.
Price AE, Liang HE, et al. Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc Natl Acad Sci U S A. 2010;107(25):11489–94.
Quinn GA, Cole AM. Suppression of innate immunity by a nasal carriage strain of Staphylococcus aureus increases its colonization on nasal epithelium. Immunology. 2007;122(1):80–9.
Redegeld FA, Nijkamp FP. Immunoglobulin free light chains and mast cells: pivotal role in T-cell-mediated immune reactions? Trends Immunol. 2003;24(4):181–5.
Reh DD, Wang Y, et al. Treatment-recalcitrant chronic rhinosinusitis with polyps is associated with altered epithelial cell expression of interleukin-33. Am J Rhinol Allergy. 2010;24(2):105–9.
Rondon C, Romero JJ, et al. Local IgE production and positive nasal provocation test in patients with persistent nonallergic rhinitis. J Allergy Clin Immunol. 2007;119(4):899–905.
Rondon C, Canto G, et al. Local allergic rhinitis: a new entity, characterization and further studies. Curr Opin Allergy Clin Immunol. 2010;10(1):1–7.
Saenz SA, Taylor BC, et al. Welcome to the neighborhood: epithelial cell-derived cytokines license innate and adaptive immune responses at mucosal sites. Immunol Rev. 2008;226:172–90.
Saenz SA, Siracusa MC, et al. IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses. Nature. 2010;464(7293):1362–6.
Schmitz J, Owyang A, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity. 2005;23(5):479–90.
Silberstein DS. Eosinophil function in health and disease. Crit Rev Oncol Hematol. 1995;19(1):47–77.
Sivakumar PV, Foster DC, et al. Interleukin-21 is a T-helper cytokine that regulates humoral immunity and cell-mediated anti-tumour responses. Immunology. 2004;112(2):177–82.
Spolski R, Leonard WJ. Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu Rev Immunol. 2008;26:57–79.
Spolski R, Leonard WJ. IL-21 and T follicular helper cells. Int Immunol. 2010;22(1):7–12.
Thurman JM, Renner B. Dynamic control of the complement system by modulated expression of regulatory proteins. Lab Invest. 2011;91(1):4–11.
Umetsu DT, DeKruyff RH. The regulation of allergy and asthma. Immunol Rev. 2006;212:238–55.
Van Bruaene N, Perez-Novo CA, et al. T-cell regulation in chronic paranasal sinus disease. J Allergy Clin Immunol. 2008;121(6):1435–41. 1441 e1431–1433.
Van Zele T, Claeys S, et al. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy. 2006;61(11):1280–9.
White J, Herman A, et al. The V beta-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell. 1989;56(1):27–35.
Yu C, Tan AH, et al. Roquin represses autoimmunity by limiting inducible T-cell co-stimulator messenger RNA. Nature. 2007;450(7167):299–303.
Zhang N, Van Zele T, et al. Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease. J Allergy Clin Immunol. 2008;122(5):961–8.
Zhang N, Holtappels G, et al. Mucosal tissue polyclonal IgE is functional in response to allergen and SEB. Allergy. 2011;66(1):141–8.
Zhou B, Comeau MR, et al. Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice. Nat Immunol. 2005;6(10):1047–53.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Appendix
Appendix
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
De Schryver, E., Calus, L., Derycke, L., Bachert, C., Gevaert, P. (2013). Local Nasal Inflammation: T Cells and B Cells. In: Önerci, T. (eds) Nasal Physiology and Pathophysiology of Nasal Disorders. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-37250-6_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-37250-6_4
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-37249-0
Online ISBN: 978-3-642-37250-6
eBook Packages: MedicineMedicine (R0)